Lipoprotein(a) plama levels during myocardial infarction

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Kaspar Broch

Oslo University Hospital Rikshospitalet, Oslo (Norway)

7 More presentations in this session

Presentation thumbnail

Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome

Doctor M. Tao (Hartford, US)

Abstract Slides Video

Presentation thumbnail

Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)

Doctor A. Bech-Drewes (Aarhus, DK)

Abstract Slides Video

Presentation thumbnail

Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome

Doctor D. Kinoshita (Yamagata, JP)

Abstract Slides Video

Presentation thumbnail

Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial

Doctor S. Hasific (Odense, DK)

Abstract Slides Video

Presentation thumbnail

The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

Mr C. Coerkamp (Amsterdam, NL)

Abstract Slides Video

Access the full session

Session thumbnail

Lipid-lowering and inflammation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

The role of lipoprotein(a) in myocardial damage and 1-year clinical outcomes after ST-segment elevation myocardial infarction

Congress Session

Determinants of long-term outcome following acute myocardial infarction

Congress Presentation

Combined effect of lipoprotein(a) and C-reactive protein on future cardiovascular outcomes after acute myocardial infarction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources